Clinical predictors of transvenous defibrillation energy requirements

The American Journal of Cardiology
K KhalighiM R Gold

Abstract

Nonthoracotomy and, more recently, transvenous lead systems have become routine for initial implantable cardioverter-defibrillator (ICD) placement. Previous studies of clinical predictors of nonthoracotomy defibrillation energy requirements evaluated multiple complex lead systems that included subcutaneous patches. However, the predictors of an adequate transvenous defibrillation threshold (DFT) have not been assessed previously. Accordingly, the present study is a prospective evaluation of DFT using a uniform testing protocol in 119 consecutive patients undergoing ICD implantation with a single transvenous lead. For each patient, 38 parameters were assessed including standard clinical, echocardiographic, and radiographic measures. An adequate monophasic DFT (< or =20 J) was achieved in 76% of patients. Multivariable analysis revealed 3 independent factors predictive of a high threshold: preoperative amiodarone use (odds ratio = 5.8, p < or =0.002), echocardiographic measures of left ventricular dilation (odds ratio = 0.47, p < or =0.005) and body size (odds ratio = 0.51, p < or =0.006). Patients receiving amiodarone who also had left ventricular dilation constitute a group at considerable (69%) risk for having a high DFT. In c...Continue Reading

References

Apr 1, 1992·Pacing and Clinical Electrophysiology : PACE·M BlockG Breithardt
Jun 1, 1992·Pacing and Clinical Electrophysiology : PACE·I Singer, D Lang
Feb 1, 1995·Pacing and Clinical Electrophysiology : PACE·D E KoppD J Wilber
Jan 1, 1995·Journal of Cardiovascular Electrophysiology·J E PooleG Johnson
Jun 1, 1995·Journal of the American College of Cardiology·M H RaittG H Bardy
Nov 1, 1994·Pacing and Clinical Electrophysiology : PACE·J S SraM Akhtar
Oct 1, 1994·Journal of the American College of Cardiology·S A StrickbergerW Kou
Jan 15, 1993·The American Journal of Cardiology·D G WyseJ Rothschild
Jun 1, 1996·Journal of Cardiovascular Electrophysiology·M R Gold, S R Shorofsky

❮ Previous
Next ❯

Citations

Aug 2, 2000·Journal of Cardiovascular Electrophysiology·P Dorian
Mar 7, 2012·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Zhongwei ChengPaul J Wang
Feb 1, 1998·Herzschrittmachertherapie & Elektrophysiologie·U WolfhardM Günnicker
Jun 4, 2010·Herzschrittmachertherapie & Elektrophysiologie·C MewisA Buob
Apr 11, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Takayuki NagaiShiro Kamakura
Nov 14, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazuya MizukamiHiroyuki Tsutsui
Nov 26, 2010·Journal of Cardiovascular Electrophysiology·Ernest M QuinMichael R Gold
Jul 29, 2010·Pacing and Clinical Electrophysiology : PACE·Brett D RobertsStephen R Shorofsky
Mar 17, 2010·Pacing and Clinical Electrophysiology : PACE·Osman FaheemChristopher A Clyne
Mar 15, 2006·Journal of Cardiovascular Electrophysiology·Luis A Pires, Katrina M Johnson
Apr 29, 2006·Journal of Cardiovascular Electrophysiology·Endre ZimaBéla Merkely
Apr 28, 2007·Pacing and Clinical Electrophysiology : PACE·Charles D SwerdlowPaul J Degroot
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Eric J RashbaMichael R Gold
Dec 2, 2009·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Gregory P WalcottRaymond E Ideker
Nov 11, 1999·Circulation·S J Connolly
Apr 1, 2016·Circulation. Arrhythmia and Electrophysiology·Kevin PhanRaymond W Sy
Mar 21, 2007·Pacing and Clinical Electrophysiology : PACE·Mintu P TurakhiaJeffrey E Olgin
Apr 18, 2013·Current Treatment Options in Cardiovascular Medicine·Maria Vittoria Matassini, Jeff S Healey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.